Statistical issues in the use of dynamic allocation methods for balancing baseline covariates

Por Pond, G R
Publicado em 2011

Fertility risk discussions in young patients diagnosed with colorectal cancer

Por Kumar, A., Merali, A., Pond, G.R., Zbuk, K.
Publicado em 2012

Factors associated with publication of randomized phase iii cancer trials in journals with a high impact factor

Por Tang, P.A., Pond, G.R., Welch, S., Chen, E.X.
Publicado em 2014

Protean manifestations of pylethrombosis. A review of thirty-four patients.

Por Witte, C L, Brewer, M L, Witte, M H, Pond, G B
Publicado em 1985

Side effects associated with the use of dexamethasone for prophylaxis of delayed emesis after moderately emetogenic chemotherapy

Por Vardy, J, Chiew, K S, Galica, J, Pond, G R, Tannock, I F
Publicado em 2006

Comparative survival in patients with brain metastases from non-small-cell lung cancer treated before and after implementation of radiosurgery

Por Greenspoon, J.N., Ellis, P.M., Pond, G., Caetano, S., Broomfield, J., Swaminath, A.
Publicado no Curr Oncol (2017)

A comparison of patient knowledge of clinical trials and trialist priorities

Por Cameron, P., Pond, G.R., Xu, R.Y., Ellis, P.M., Goffin, J.R.
Publicado em 2013

Effects on bone resorption markers of continuing pamidronate or switching to zoledronic acid in patients with high risk bone metastases from breast cancer

Por Hilton, J.F., Clemons, M., Pond, G., Zhao, H., Mazzarello, S., Vandermeer, L., Addison, C.L.
Publicado no J Bone Oncol (2017)

Metformin inhibits growth and enhances radiation response of non-small cell lung cancer (NSCLC) through ATM and AMPK

Por Storozhuk, Y, Hopmans, S N, Sanli, T, Barron, C, Tsiani, E, Cutz, J-C, Pond, G, Wright, J, Singh, G, Tsakiridis, T
Publicado em 2013

Can the referring surgeon enhance accrual of breast cancer patients to medical and radiation oncology trials? The ENHANCE study

Por Arnaout, A., Kuchuk, I., Bouganim, N., Pond, G., Verma, S., Segal, R., Dent, S., Gertler, S., Song, X., Kanji, F., Clemons, M.
Publicado no Curr Oncol (2016)

Fatigue in people with localized colorectal cancer who do and do not receive chemotherapy: a longitudinal prospective study

Por Vardy, J. L., Dhillon, H. M., Pond, G. R., Renton, C., Dodd, A., Zhang, H., Clarke, S. J., Tannock, I. F.
Publicado no Ann Oncol (2016)

A phase 2 trial exploring the clinical and correlative effects of combining doxycycline with bone-targeted therapy in patients with metastatic breast cancer

Por Addison, C.L., Simos, D., Wang, Z., Pond, G., Smith, S., Robertson, S., Mazzarello, S., Singh, G., Vandermeer, L., Fernandes, R., Iyengar, A., Verma, S., Clemons, M.
Publicado no J Bone Oncol (2016)

Phase II study of erlotinib (OSI-774) in patients with metastatic colorectal cancer

Por Townsley, C A, Major, P, Siu, L L, Dancey, J, Chen, E, Pond, G R, Nicklee, T, Ho, J, Hedley, D, Tsao, M, Moore, M J, Oza, A M
Publicado em 2006

Cognitive function and fatigue after diagnosis of colorectal cancer

Por Vardy, J., Dhillon, H. M., Pond, G. R., Rourke, S. B., Xu, W., Dodd, A., Renton, C., Park, A., Bekele, T., Ringash, J., Zhang, H., Burkes, R., Clarke, S. J., Tannock, I. F.
Publicado no Ann Oncol (2014)

A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas

Por Duran, I, Kortmansky, J, Singh, D, Hirte, H, Kocha, W, Goss, G, Le, L, Oza, A, Nicklee, T, Ho, J, Birle, D, Pond, G R, Arboine, D, Dancey, J, Aviel-Ronen, S, Tsao, M-S, Hedley, D, Siu, L L
Publicado em 2006